Form 4 for TTI TETRA TECHNOLOGIES INC
Accepted 2025-11-12 00:00:00 ET · period of report 2025-11-10 · accession 0001876303-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-12 | 2025-11-10 | TTI | Boston Shoemake Alicia r | SVP, GC | M - OptEx | $4.91 | +19.3K | 145.8K | +15% | +$94.6K |
| DM | 2025-11-12 | 2025-11-10 | TTI | Boston Shoemake Alicia r | SVP, GC | S - Sale+OE | $7.94 | -19.3K | 132.7K | -13% | -$152.9K |
| DM | 2025-11-12 | 2025-11-10 | TTI | Boston Shoemake Alicia r | SVP, GC | M - OptEx | $0.00 | -19.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-10 | M | A | 6,142 | $7.14 | 138,814 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-10 | S | D | 6,142 | $7.90 | 132,672 | D | — | — | (F2) The price reported reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $7.88 to $7.94. (F1) These options were exercised and the underlying shares sold to manage the reporting person's personal investment portfolio and liquidity needs. The exercise and sale were conducted in a manner consistent with the filing person's overall financial strategy. The reporting person remains in compliance with the Issuer's stock ownership guidelines. |
| 3 | Common | Common Stock | 2025-11-10 | M | A | 13,115 | $3.87 | 145,787 | D | — | — | |
| 4 | Common | Common Stock | 2025-11-10 | S | D | 13,115 | $7.96 | 132,672 | D | — | — | (F4) The price reported reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $7.925 to $8.01. (F3) These options were exercised and the underlying shares sold to manage the reporting person's personal investment portfolio and liquidity needs. The exercise and sale were conducted in a manner consistent with the filing person's overall financial strategy. The reporting person remains in compliance with the Issuer's stock ownership guidelines. |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-11-10 | M | D | 6,142 | $0.00 | 0 | D | $7.14 · — to 2026-05-02 | 6,142 Common Stock | (F5) The incentive stock options vest 33.3334% on the one-year anniversary of the grant date and then in equal monthly installments until fully vested on May 2, 2019. |
| 6 | Derivative | Stock Option (Right to Buy) | 2025-11-10 | M | D | 13,115 | $0.00 | 0 | D | $3.87 · — to 2028-02-22 | 13,115 Common Stock | (F6) The incentive stock options vest 33.3334% on the one-year anniversary of the grant date and then in equal monthly installments until fully vested on February 22, 2021. |